# Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer.

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/phase-ii-study-of-weekly-intravenous-recombinant-humanized-anti-p185her2/

## Facts

| Field | Value |
| --- | --- |
| Author Names | José Baselga,Debu Tripathy,John Mendelsohn,Sharon A. Baughman,Christopher C. Benz,L Dantis,Nancy T. Sklarin,Andrew D. Seidman,Clifford A. Hudis,J. Moore,Paul Peter Rosen,T. Twaddell,I. Craig Henderson,Larry Norton |
| Citations | 1,403 |
| DOI | 10.1200/jco.1996.14.3.737 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2222638000 |
| PMID | 8622019 |
| Type | article |
| Year | 1996 |

## Paper authors

- [Clifford A. Hudis](https://scholariq.org/researchers/clifford-a-hudis/)
- [Larry Norton](https://scholariq.org/researchers/larry-norton/)

## Paper journal

- [Journal of Clinical Oncology](https://scholariq.org/journals/journal-of-clinical-oncology/)

## Paper primary topic

- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)

## Paper topics

- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Monoclonal and Polyclonal Antibodies Research](https://scholariq.org/topics/monoclonal-and-polyclonal-antibodies-research/)
- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.